Sven Weiler
11Patents
3h-index
40Co-inventors
56Inventor score
Filing activity: Jun 14, 2002 → May 27, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8367662B2 | Organic compounds | Human Necessities | 7 | Active |
| US8476286B2 | Quinazoline derivatives which promote the release of parathyroid hormone | Chemistry; Metallurgy | 5 | Expired |
| US10710980B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 4 | Active |
| US10947218B2 | Aminopyridine derivatives and their use as selective ALK-2 inhibitors | Emerging Cross-Sectional Technologies | 2 | Active |
| US7696216B2 | Aryl-quinazoline/aryl-2-amino-phenyl methanone derivatives | Chemistry; Metallurgy | 1 | Active |
| US8569317B2 | Aryl-quinazoline/aryl-2amino-phenyl methanone derivatives | Chemistry; Metallurgy | 0 | Active |
| US11160797B2 | Pyridinone derivatives and their use as selective ALK-2 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8841291B2 | Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7977323B2 | C2-C5-alkyl-imidazole-bisphosphonates | Human Necessities | 0 | Active |
| US8030497B2 | Benzimidazole derivatives | Chemistry; Metallurgy | 0 | Active |
| US8143253B2 | Organic compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.